EMA: Regulatory information - adjusted fees for applications to European Medicines Agency from 1 April 2016

The European Medicines Agency reminds applicants and marketing-authorisation holders that adjusted fees for all applications, except for pharmacovigilance procedures, will be coming into effect on Friday 1 April 2016. Every year, the Agency adjusts its fees on 1 April, in line with the European Union (EU) inflation rate for the previous year. The European Commission is currently in the process of adopting a regulation adjusting the fees payable to the Agency by 0.2% in line with the 2015 inflation rate.